LEXISCAN is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Regadenoson.
| Product ID | 0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10 |
| NDC | 0469-6501 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LEXISCAN |
| Generic Name | Regadenoson |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2008-04-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022161 |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | REGADENOSON |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2008-04-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022161 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2008-04-10 |
| Marketing End Date | 2011-10-20 |
| Marketing Category | NDA |
| Application Number | NDA022161 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2008-04-10 |
| Ingredient | Strength |
|---|---|
| REGADENOSON | .08 mg/mL |
| SPL SET ID: | 057289f4-2e18-4c1e-bed4-6c1858e2ef16 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0469-6501 | LEXISCAN | regadenoson |
| 55150-443 | regadenoson | regadenoson |
| 68083-175 | Regadenoson | Regadenoson |
| 71288-201 | Regadenoson | Regadenoson |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LEXISCAN 78890527 3503116 Live/Registered |
Astellas US LLC 2006-05-23 |